[go: up one dir, main page]

ATE362547T1 - Polymorphismen im menschlichen kdr gene - Google Patents

Polymorphismen im menschlichen kdr gene

Info

Publication number
ATE362547T1
ATE362547T1 AT01309193T AT01309193T ATE362547T1 AT E362547 T1 ATE362547 T1 AT E362547T1 AT 01309193 T AT01309193 T AT 01309193T AT 01309193 T AT01309193 T AT 01309193T AT E362547 T1 ATE362547 T1 AT E362547T1
Authority
AT
Austria
Prior art keywords
polymorphisms
kdr
relates
sequence
snps
Prior art date
Application number
AT01309193T
Other languages
English (en)
Inventor
John Craig Smith
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0026851A external-priority patent/GB0026851D0/en
Priority claimed from GB0109602A external-priority patent/GB0109602D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE362547T1 publication Critical patent/ATE362547T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT01309193T 2000-11-03 2001-10-30 Polymorphismen im menschlichen kdr gene ATE362547T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0026851A GB0026851D0 (en) 2000-11-03 2000-11-03 Chemical compounds
GB0109602A GB0109602D0 (en) 2001-04-19 2001-04-19 Chemical compounds

Publications (1)

Publication Number Publication Date
ATE362547T1 true ATE362547T1 (de) 2007-06-15

Family

ID=26245232

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01309193T ATE362547T1 (de) 2000-11-03 2001-10-30 Polymorphismen im menschlichen kdr gene

Country Status (6)

Country Link
US (2) US20030129596A1 (de)
EP (2) EP1203827B1 (de)
JP (1) JP2002345489A (de)
AT (1) ATE362547T1 (de)
DE (1) DE60128434T2 (de)
ES (1) ES2284596T3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007109515A2 (en) * 2006-03-20 2007-09-27 Novartis Ag Mutations and polymorphisms of knockdown resistance polypeptide
WO2008128233A1 (en) * 2007-04-15 2008-10-23 University Of Chicago Methods and compositions concerning the vegfr-2 gene (kinase domain receptor, kdr)
CA2698117C (en) 2007-04-26 2019-02-26 The Regents Of The University Of Michigan Fig4 gene mutations in neurodegeneration
GB201410693D0 (en) 2014-06-16 2014-07-30 Univ Southampton Splicing modulation
SG11201702682PA (en) 2014-10-03 2017-04-27 Cold Spring Harbor Lab Targeted augmentation of nuclear gene output
CN107075565B (zh) * 2014-11-21 2021-07-27 深圳华大生命科学研究院 个体单核苷酸多态性位点分型方法及装置
CN104726608B (zh) * 2015-04-13 2016-05-25 中南大学湘雅医院 VEGFR2基因Val297Ile位点的应用方法
US10196639B2 (en) 2015-10-09 2019-02-05 University Of Southampton Modulation of gene expression and screening for deregulated protein expression
JP7049248B2 (ja) 2015-12-14 2022-04-06 コールド スプリング ハーバー ラボラトリー 常染色体優性精神遅滞－５とドラベ症候群の処置のためのアンチセンスオリゴマー
US11096956B2 (en) 2015-12-14 2021-08-24 Stoke Therapeutics, Inc. Antisense oligomers and uses thereof
KR102318434B1 (ko) 2017-08-25 2021-11-01 스톡 테라퓨틱스, 인크. 병태 및 질환 치료용 안티센스 올리고머
US12060558B2 (en) 2018-05-04 2024-08-13 Stoke Therapeutics, Inc. Methods and compositions for treatment of cholesteryl ester storage disease
IL298063A (en) 2020-05-11 2023-01-01 Stoke Therapeutics Inc opa1 antisense oligomers for the treatment of conditions and diseases

Also Published As

Publication number Publication date
EP1203827A3 (de) 2002-10-30
EP1469084A3 (de) 2005-08-17
EP1203827A2 (de) 2002-05-08
DE60128434T2 (de) 2008-02-14
US20050059067A1 (en) 2005-03-17
US20030129596A1 (en) 2003-07-10
DE60128434D1 (de) 2007-06-28
ES2284596T3 (es) 2007-11-16
EP1203827B1 (de) 2007-05-16
EP1469084A2 (de) 2004-10-20
JP2002345489A (ja) 2002-12-03

Similar Documents

Publication Publication Date Title
DE60128434D1 (de) Polymorphismen im menschlichen KDR Gene
IL158261A0 (en) New polynucleotides and polypeptides of the erythropoietin gene
ATE269402T1 (de) Ikk-beta proteine, nukleinsäuren und verfahren
ATE407949T1 (de) Charakterisierung der proteinfamilie von soc/crac kalziumkanälen
DE69941059D1 (de) Nukleotid- und proteinsequenzen von nogo-genen und darauf beruhende methoden
PT1673473E (pt) Utilização de polimorfismos genéticos associados à eficácia do tratamento de doenças inflamatórias
ATE309812T1 (de) Verwendung von adenoviren mit mutationen in den va-genen für die krebstherapie
FR2823764B1 (fr) Nouveaux polynucleotides et polypeptides du gene ifn alpha-17
EE200100472A (et) Polüpeptiid, antikehad, lahustuv polüpeptiid, polü- või oligonukleotiid ja meetod diferentsiaalseltekspresseerunud DNA järjestuste spetsiifiliseks identifitseerimiseks
DE69816467D1 (de) Robo: eine familie polypeptiden und nukleinesäuren wirksam in nervenzellleitung
ATE513033T1 (de) Expression von proteinen in aus nabelschnurblut gewonnenen endothelzellen
WO2002095067A3 (en) INTERFERON α-14 POLYMORPHISM
AR029627A1 (es) Derivados de proteina c y composiciones farmaceuticas formuladas con dichos derivados, moleculas de dna recombinante que codifican dichos derivados; vectores de transformacion que comprenden dichos derivados; aislados de acidos nucleicos que comprenden polinucleotidos que codifican al menos el 90% d
WO2005110039A3 (en) Genetic polymorphisms associated with vascular diseases, methods of detection and uses thereof
WO2000058510A3 (en) Schizophrenia associated genes, proteins and biallelic markers
WO2003000896A3 (en) POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE
WO2002072632A3 (en) Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof.
EP0771874A3 (de) Vorbereitung transgenischer Proteine
WO2002046458A3 (en) Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof
DK1630232T3 (da) Optimerede nukleotidsekvenser kodende for sgp130
WO2002101048A3 (en) NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
WO2000006769A3 (en) Human ccr-2 gene polymorphisms
ATE374260T1 (de) Asthma-assoziiertes gen
WO2002083733A3 (en) Polynucleotides and polypeptides of the ifnalpha-6 gene
DE69027967D1 (de) Proteine, die die expression von vertebraten-mhc-klasse-ii-genen regulieren, dafür kodierende dna-sequenzen und pharmazeutische zusammensetzungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties